X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Strides Arcolab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs STRIDES SHASUN LTD - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

STRIDES SHASUN LTD 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. STRIDES SHASUN LTD WOCKHARDT LTD./
STRIDES SHASUN LTD
 
P/E (TTM) x -18.2 15.2 - View Chart
P/BV x 3.0 1.8 168.9% View Chart
Dividend Yield % 1.1 0.6 197.1%  

Financials

 WOCKHARDT LTD.   STRIDES SHASUN LTD
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-17
STRIDES SHASUN LTD
Mar-17
WOCKHARDT LTD./
STRIDES SHASUN LTD
5-Yr Chart
Click to enlarge
High Rs1,1291,275 88.6%   
Low Rs627918 68.3%   
Sales per share (Unadj.) Rs363.1389.6 93.2%  
Earnings per share (Unadj.) Rs-20.428.0 -73.1%  
Cash flow per share (Unadj.) Rs-7.048.9 -14.3%  
Dividends per share (Unadj.) Rs10.004.50 222.2%  
Dividend yield (eoy) %1.10.4 277.5%  
Book value per share (Unadj.) Rs301.8303.1 99.6%  
Shares outstanding (eoy) m110.5589.42 123.6%   
Bonus/Rights/Conversions ISESOP-  
Price / Sales ratio x2.42.8 85.9%   
Avg P/E ratio x-42.939.2 -109.5%  
P/CF ratio (eoy) x-125.922.4 -561.4%  
Price / Book Value ratio x2.93.6 80.4%  
Dividend payout %-48.916.1 -304.0%   
Avg Mkt Cap Rs m97,06398,036 99.0%   
No. of employees `0006.85.8 116.7%   
Total wages/salary Rs m9,6655,881 164.3%   
Avg. sales/employee Rs Th5,931.86,005.9 98.8%   
Avg. wages/employee Rs Th1,428.11,014.0 140.8%   
Avg. net profit/employee Rs Th-334.0431.2 -77.5%   
INCOME DATA
Net Sales Rs m40,14634,834 115.2%  
Other income Rs m1,1431,686 67.8%   
Total revenues Rs m41,28936,520 113.1%   
Gross profit Rs m1286,428 2.0%  
Depreciation Rs m1,4891,872 79.6%   
Interest Rs m2,2532,269 99.3%   
Profit before tax Rs m-2,4723,973 -62.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m04 0.0%   
Extraordinary Inc (Exp) Rs m0-1,006 0.0%   
Tax Rs m-211470 -44.9%   
Profit after tax Rs m-2,2602,501 -90.4%  
Gross profit margin %0.318.5 1.7%  
Effective tax rate %8.511.8 72.2%   
Net profit margin %-5.67.2 -78.4%  
BALANCE SHEET DATA
Current assets Rs m46,16038,165 120.9%   
Current liabilities Rs m19,25830,402 63.3%   
Net working cap to sales %67.022.3 300.7%  
Current ratio x2.41.3 190.9%  
Inventory Days Days10177 130.3%  
Debtors Days Days94104 90.0%  
Net fixed assets Rs m40,16537,639 106.7%   
Share capital Rs m553894 61.8%   
"Free" reserves Rs m32,81426,210 125.2%   
Net worth Rs m33,36727,105 123.1%   
Long term debt Rs m31,90316,377 194.8%   
Total assets Rs m89,68781,168 110.5%  
Interest coverage x-0.12.8 -3.5%   
Debt to equity ratio x1.00.6 158.2%  
Sales to assets ratio x0.40.4 104.3%   
Return on assets %05.9 -0.1%  
Return on equity %-6.89.2 -73.4%  
Return on capital %-0.312.1 -2.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,12113,465 67.7%   
Fx outflow Rs m2,1334,076 52.3%   
Net fx Rs m6,9889,389 74.4%   
CASH FLOW
From Operations Rs m-2,6952,881 -93.5%  
From Investments Rs m-6,863-7,051 97.3%  
From Financial Activity Rs m12,5453,382 370.9%  
Net Cashflow Rs m3,010-788 -382.2%  

Share Holding

Indian Promoters % 74.5 27.7 269.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 37.8 6.1%  
FIIs % 7.7 8.6 89.5%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 25.9 59.5%  
Shareholders   67,757 56,241 120.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   GLENMARK PHARMA  FULFORD INDIA  MERCK LTD  DIVIS LABORATORIES  UNICHEM LAB  

Compare WOCKHARDT LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Jan 19, 2018 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. - DISHMAN PHARMA COMPARISON

COMPARE WOCKHARDT LTD. WITH

MARKET STATS